Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
Journal
-
- The Lancet Oncology
-
The Lancet Oncology 15 (8), 894-904, 2014-07
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1364233269046589056
-
- ISSN
- 14702045
-
- Data Source
-
- Crossref